The effectiveness of deferasirox to prevent from the occurrence of liver fibrosis in balb/c mice with iron overload

Authors

  • Hadi Sarosa Physiology Department of Medical Faculty, Universitas Islam Sultan Agung
  • Wildan Chanieful Wajiih Student of Medical Faculty, Universitas Islam Sultan Agung
  • Ulfah Dian Indrayani Histology Department of Medical Faculty, Universitas Islam Sultan Agung

DOI:

https://doi.org/10.3329/bjms.v22i1.61865

Keywords:

Deferasirox; Iron chelation; Iron overload; TGF β; and Liver fibrosis.

Abstract

Background: Oxidation of hepatocyte mitochondria due to iron overload led to hepatocyte injury, elevated Transforming growth factor- β (TGF- β), and fibrosis. Fibrosis starts with stellate cell fibrogenesis activated by chronic hepatocyte injury. Liver fibrosis is the main cause of morbidity and mortality in iron overload. Deferasirox is an iron chelation drug serving to bind iron overload and have an antifibrotic effect.

Aim: To examine the effect of deferasirox on liver fibrosis prevention due to iron overload.

Methods: This experimental research used a post-test only control group design on male Balb/c mice that were randomly divided into 3 groups, each n=5. Group 1 (NaCl+S) was administered with 0.3 cc Na Cl 0.9% through intra peritoneal (I.P) injection and drug solvent (Aquabidest, CMC and Nipagin) per oral (P.O) intermittently. Group 2 (Fe+S) was administered with 0.3 cc 1.5 mg Fe+sucrose (Venofer®) through I.P injection and drug solvent (Aquabidest, CMC and Nipagin) P.O intermittently. Group 3 (Fe+Dfx) 0.3 cc 1.5 mg Fe+sucrose (Venofer®) I.P injection, and deferasirox 20 mg/kgBW/day P.O intermittently. All of the treatments were given for 60 days. The fibrosis area fraction of the liverwas assessed using software ImageJ.

Results: The average fibrosis area fraction of group 1 was 0.00 ± 0.00%, group 2 was 9.17 ± 8.54% and group 3 was 1.38 ± 0.20%. The fibrosis area fractions between groups 2 and 3 were significantly different with p value 0.000 (p<0.05). The body weight of group 2 was higher than that of groups 3 and 1.

Conclusions: Iron overload causes liver fibrosis in male Balb/c mice. Deferasirox administration may lower the area of liver fibrosis in male Balb/c mice due to iron overload.

Bangladesh Journal of Medical Science Vol. 22 No. 01 January’23 Page : 84-90

Downloads

Download data is not yet available.
Abstract
38
PDF
54

Downloads

Published

2023-01-01

How to Cite

Sarosa, H. ., Wajiih, W. C. ., & Indrayani, U. D. . (2023). The effectiveness of deferasirox to prevent from the occurrence of liver fibrosis in balb/c mice with iron overload. Bangladesh Journal of Medical Science, 22(1), 84–90. https://doi.org/10.3329/bjms.v22i1.61865

Issue

Vol. 22 No. 1 (2023)

Section

Original Articles

License

Copyright (c) 2022 Hadi Sarosa, Wildan Chanieful Wajiih, Ulfah Dian Indrayani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.